| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 07/27/2005 | CN1646480A Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition |
| 07/27/2005 | CN1646143A Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 07/27/2005 | CN1646139A Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system |
| 07/27/2005 | CN1646133A Pharmaceutical combinations of cox-2 inhibitors and opiates |
| 07/27/2005 | CN1646131A Novel compounds |
| 07/27/2005 | CN1646093A Method and composition for treatment of inflammation and AIDS-associated neurological disorders |
| 07/26/2005 | US6921774 Administering compounds such as N-(3-(5-Cyano-1-(4-fluoro-phenyl)-1,3-dihydroisobenzofuran-1-yl)-1 -propyl)glycine ethyl ester, for prophylaxis of psychological disorders |
| 07/26/2005 | US6921771 Administering a fused aminoquinoline derivative such as (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo(4,5,1-ij) quinoline-2(1H)-thione or pharmaceutically acceptable salts |
| 07/26/2005 | US6921762 Substituted indolizine-like compounds and methods of use |
| 07/26/2005 | CA2470200C Pharmaceutical composition |
| 07/26/2005 | CA2315481C Selective inhibition of aggrecanase in osteoarthritis treatment |
| 07/26/2005 | CA2285203C Compositions containing capsaicin or capsaicin analogues and a local anesthetic |
| 07/21/2005 | US20050159475 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 07/21/2005 | US20050159474 Chemical compounds |
| 07/21/2005 | US20050159452 Nociceptin analogs |
| 07/21/2005 | US20050159451 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 07/21/2005 | US20050159445 Selective iGluR5 receptor antagonists |
| 07/21/2005 | US20050159359 Methods and compositions for derepression of IAP-inhibited caspase |
| 07/21/2005 | US20050158288 Methods of organ regeneration |
| 07/20/2005 | EP1554312A2 Neutralizing antibodies against gdf-8 and uses therefor |
| 07/20/2005 | EP1554253A1 Imidazolium cxcr3 inhibitors |
| 07/20/2005 | EP1401467A4 Alpha-fetoprotein peptides and uses thereof |
| 07/20/2005 | EP1272484B1 Benzoamide piperidine compounds as substance p antagonists |
| 07/20/2005 | EP1261328B1 Il-8 receptor antagonists |
| 07/20/2005 | EP1241254B1 Apoptosis inhibitory polypeptide, gene and polynucleotide encoding it and compositions containing the same |
| 07/20/2005 | EP1198570B1 Monomeric protein of the tgf-beta family |
| 07/20/2005 | EP0828851B1 Tripeptidylpeptidase inhibitors |
| 07/20/2005 | EP0703785B1 Methods for treating muscle diseases and disorders |
| 07/20/2005 | CN1643135A Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 07/20/2005 | CN1642983A Antibodies against of C5aR and use thereof |
| 07/20/2005 | CN1642980A Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 07/20/2005 | CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642945A Stable hydrate of a muscarinic receptor antagonist |
| 07/20/2005 | CN1642938A New compounds |
| 07/20/2005 | CN1642933A Cyclic hemiacetal derivative and use thereof |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642573A Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 07/20/2005 | CN1642558A Theraputic methods and uses of sapogenins and their derivatives |
| 07/20/2005 | CN1642551A Inhibitors of histone deacetylase |
| 07/20/2005 | CN1642528A Stable salts of O-acetylsalicylic acid containing basic amino acids II |
| 07/20/2005 | CN1211374C Heterocyclic derivative, its preparation method and medicine compositioncontaining them |
| 07/19/2005 | US6919470 Aryl and heteroaryl sulfonates |
| 07/19/2005 | US6919438 Comprises viral expression vector coding envelope protein domains for use as gene therapeutic tool in the treatment of autoimmune diseases |
| 07/19/2005 | US6919362 For use as hypoglycaemic and hypolipidaemic agents |
| 07/19/2005 | US6919355 Amide derivatives as NMDA receptor antagonists |
| 07/19/2005 | US6919353 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 07/19/2005 | US6919343 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives |
| 07/19/2005 | US6919340 Kinase moderators; controlling gene expression; immunosuppressants; autoimmune disease; rheumatic disorders; skin disorders; antitumor agents; anticancer agents |
| 07/19/2005 | US6919330 Formulations of drugs |
| 07/19/2005 | US6919307 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 07/14/2005 | WO2005009480A3 Implants containing codrugs |
| 07/14/2005 | WO2003059294A3 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 07/14/2005 | US20050154165 Ph-sensitive polymer |
| 07/14/2005 | US20050154023 1-(4-methoxynaphthalene-1-sulfonyl)-2,3-dihydro-1H-indole-3-carboxylic acid [2-(1-methyl-pyrrolidin-2-yl)-ethyl]amide; selective affinity for 5-HT6 receptor; psychosis, schizophrenia, depression, neurological disorders, cognitive enhancement, Parkinson's disease, ALS, Alzheimer's, Huntington's disease |
| 07/14/2005 | US20050154019 Substituted cyclic amine metalloprotease inhibitors |
| 07/14/2005 | US20050154005 Administering to a subject in need of such treatment an effective amount of 1,1'-[1,4-(phenylenebis(methylene))]bis-1,4,8,11-tetraazacyclotetradecane or a pharmaceutical composition thereof, wherein the inhibition of CXCR4 receptor binding effects treatment or amelioration of said condition |
| 07/14/2005 | US20050153988 Novel polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
| 07/14/2005 | US20050153987 Compounds |
| 07/14/2005 | US20050153980 Substituted indoles |
| 07/14/2005 | US20050153960 Substituted arylamine derivatives and methods of use |
| 07/14/2005 | US20050153917 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 07/14/2005 | US20050153889 Modulation of pericyte proliferation |
| 07/14/2005 | US20050153888 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells |
| 07/14/2005 | US20050153315 Nucleotide sequences coding polypeptide comprising methylarginase activities for use in identifying modulator for prevention and treatment of ischemia-reperfusion injuries, cancer, hypotension, multi-organ failure, arthritis, skin, inflammatory, cardiac and/or migraine disorders |
| 07/14/2005 | US20050152959 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell |
| 07/14/2005 | US20050152870 Pharmaceutical composition which improves in vivo gene transfer |
| 07/14/2005 | CA2551552A1 5-ht2 receptors modulators, their pharmaceuticals compositions and their use for the treatment of cardiovascular and muscle diseases |
| 07/14/2005 | CA2550383A1 Methods and compositions for directing migration of neural progenitor cells |
| 07/13/2005 | EP1552838A1 Rubrofusarin glycoside-containing composition |
| 07/13/2005 | EP1552834A1 Neurotrophic factor production promoter |
| 07/13/2005 | EP1551865A2 Hybrid molcules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 07/13/2005 | EP1551848A1 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 07/13/2005 | EP1551837A1 Phosphodiesterase 4 inhibitors |
| 07/13/2005 | EP1551793A1 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 07/13/2005 | EP1551430A2 Botulinum toxin dental therapies and procedures |
| 07/13/2005 | EP1551416A2 Method for treating erectile dysfunction and increasing libido in men |
| 07/13/2005 | EP1551412A1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 07/13/2005 | EP1202722B1 Uses of compositions for treating or preventing sleep disturbances using very low doses of cyclobenzaprine |
| 07/13/2005 | EP1161415B1 N-cyanomethylamides as protease inhibitors |
| 07/13/2005 | CN1639132A N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/13/2005 | CN1639125A New inhibitors of histone deacetylase |
| 07/13/2005 | CN1638799A Human mast cell-expressed membrane proteins |
| 07/13/2005 | CN1638793A Pharmaceutical and cosmetic compositions comprising PLGF-1 |
| 07/13/2005 | CN1638783A Treatment of muscular distrophy with cord blood cells |
| 07/13/2005 | CN1638765A Mediators of Hedgehog signaling pathways, compositions and uses related thereto |
| 07/13/2005 | CN1638762A Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists |
| 07/13/2005 | CN1638760A Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 07/13/2005 | CN1638753A Potentiation of therapeutic effects of fatty acids |
| 07/13/2005 | CN1638747A Sustained release pharmaceutical composition |
| 07/13/2005 | CN1636991A Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/13/2005 | CN1636980A 二肽腈组织蛋白酶k抑制剂 Dipeptide nitrile cathepsin inhibitors k |
| 07/13/2005 | CN1636572A Compositions and methods for treatment of mitochondrial diseases |
| 07/13/2005 | CN1636566A Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 07/13/2005 | CN1210274C Piperazine and piperidine derivatives |
| 07/13/2005 | CN1210273C Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 07/13/2005 | CN1210262C Method for preparing methylsulfonate trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperid-1-yl)-1-propanol |
| 07/13/2005 | CN1210066C Cloning pigs using donor nuclei from differentiated cells |
| 07/13/2005 | CN1210046C Medicine for treating muscle atrophy |
| 07/12/2005 | US6916826 Substituted imidazo[1,2-a]pyridine derivatives |